Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-27 01:43 |
Annual General Meeting of Shareholders will be held on Thursday, August 8 2024,…
|
English | 1.0 MB | ||
| 2024-06-27 01:43 |
Annual General Meeting of Shareholders will be held on Thursday, August 8 2024,…
|
English | 36.9 KB | ||
| 2024-06-20 18:24 |
6K: The Tel Aviv District Court dismissed the previously disclosed lawsuit and …
|
English | 124.5 KB | ||
| 2024-06-20 18:24 |
6K: The Tel Aviv District Court dismissed the previously disclosed lawsuit and …
|
English | 36.9 KB | ||
| 2024-06-05 09:59 |
6K-Corporate Presentation June 2024
|
English | 18.3 MB | ||
| 2024-06-05 09:59 |
6K-Corporate Presentation June 2024
|
English | 36.6 KB | ||
| 2024-06-03 15:30 |
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data…
|
English | 208.1 KB | ||
| 2024-06-03 15:30 |
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data…
|
English | 36.8 KB | ||
| 2024-06-02 01:06 |
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2
Dat…
|
English | 320.6 KB | ||
| 2024-06-02 01:06 |
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2
Dat…
|
English | 35.9 KB | ||
| 2024-05-21 16:48 |
First Quarter 2024 Financial Results and Provides Business Update
|
English | 218.1 KB | ||
| 2024-05-21 16:48 |
First Quarter 2024 Financial Results and Provides Business Update
|
English | 36.8 KB | ||
| 2024-05-05 01:31 |
CORPORATE PRESENTATION
|
English | 2.0 MB | ||
| 2024-05-05 01:31 |
CORPORATE PRESENTATION
|
English | 36.6 KB | ||
| 2024-04-25 16:18 |
Purple Biotech’s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as La…
|
English | 189.4 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
